Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8250
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
0.8356
+0.0106 (1.28%)
After-hours: Mar 28, 2025, 7:46 PM EDT
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $50.30 million as of March 28, 2025. Its market cap has decreased by -25.96% in one year.
Market Cap
50.30M
Enterprise Value
-37.22M
1-Year Change
-25.96%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $50.30M, a decrease of -94.98%. That is a compound annual growth rate of -48.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 50.30M | -12.25% |
| Dec 31, 2024 | 57.32M | -21.36% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |